Great Oak Capital Partners Boosts Johnson & Johnson Holdings

Institutional investor increases stake in healthcare giant by over 300%

Mar. 22, 2026 at 7:51am

Got story updates? Submit your updates here. ›

Great Oak Capital Partners LLC, an institutional investor, significantly increased its holdings in Johnson & Johnson (NYSE: JNJ) by 336.9% in the fourth quarter, according to a recent SEC filing. The firm now owns 7,322 shares of the company's stock, valued at $1.52 million.

Why it matters

Johnson & Johnson is a bellwether healthcare stock, and changes in institutional ownership can signal broader market trends and investor sentiment around the company and the industry. Great Oak Capital Partners' substantial increase in its JNJ position suggests the firm sees value and growth potential in the stock.

The details

According to the 13F filing, Great Oak Capital Partners purchased an additional 5,646 shares of Johnson & Johnson in the fourth quarter, bringing its total position to 7,322 shares. This represents a 336.9% increase in the firm's holdings of the healthcare conglomerate's stock.

  • Great Oak Capital Partners filed the 13F report disclosing the increased JNJ holdings on March 22, 2026.
  • The firm made the stock purchases during the fourth quarter of 2025.

The players

Great Oak Capital Partners LLC

An institutional investment firm that manages a portfolio of stocks, including a significant position in healthcare giant Johnson & Johnson.

Johnson & Johnson

A multinational pharmaceutical and medical devices company headquartered in New Brunswick, New Jersey. It is one of the most broadly based healthcare companies in the world.

Got photos? Submit your photos here. ›

The takeaway

Great Oak Capital Partners' substantial increase in its Johnson & Johnson holdings suggests the firm sees strong growth potential in the healthcare conglomerate's stock. As a bellwether in the industry, JNJ's performance is closely watched by investors and analysts alike.